| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Wendell Amy McBride is a Director at Axogen, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 7 buys and 5 sells.
Estimated insider holdings value: $6.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | SOLV Solventum Corporation | Director | Buy | 1,475 | $68.03 | $100,344.25 | +41.4% | - | - | |
| Dec 16, 2025 | AXGN Axogen, Inc. | Director | Sale+OE | 43,684 | $29.31 | $1,280,465.41 | -11.4% | +11.9% | - | |
| Jun 9, 2025 | AXGN Axogen, Inc. | Director | Sell | 4,073 | $10.61 | $43,214.53 | -4.2% | +54.1% | - | |
| Mar 3, 2025 | AXGN Axogen, Inc. | Director | Sell | 5,000 | $20.02 | $100,100.00 | -4.9% | -43.1% | +54.5% | |
| Sep 6, 2023 | AXGN Axogen, Inc. | Director | Buy | 10,000 | $6.22 | $62,240.00 | +14.2% | +12.8% | +115.4% | |
| Jun 13, 2019 | AXGN Axogen, Inc. | Director | Buy | 5,000 | $20.25 | $101,250.00 | +27.3% | - | - | |
| Aug 14, 2018 | AXGN Axogen, Inc. | Director | Buy | 5,000 | $36.89 | $184,450.00 | +37.5% | - | - | |
| Mar 14, 2018 | HOLX Hologic Inc | Director | Buy | 5,200 | $38.43 | $199,825.60 | +102.0% | - | - | |
| Sep 14, 2017 | EKSO Ekso Bionics Holdings, Inc. | Director | Buy | 16,264 | $1.23 | $20,004.72 | New | - | - | |
| Oct 7, 2016 | AXGN Axogen, Inc. | Director | Buy | 13,333 | $7.50 | $99,997.50 | New | - | - |